New Age Alpha Advisors LLC Sells 16,831 Shares of Encompass Health Corporation $EHC

New Age Alpha Advisors LLC reduced its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 42.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,023 shares of the company’s stock after selling 16,831 shares during the period. New Age Alpha Advisors LLC’s holdings in Encompass Health were worth $2,444,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. EP Wealth Advisors LLC lifted its stake in Encompass Health by 2.4% in the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock worth $453,000 after acquiring an additional 88 shares during the period. Allworth Financial LP lifted its stake in Encompass Health by 14.7% in the third quarter. Allworth Financial LP now owns 701 shares of the company’s stock worth $89,000 after acquiring an additional 90 shares during the period. Westside Investment Management Inc. lifted its stake in Encompass Health by 56.7% in the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after acquiring an additional 101 shares during the period. Vanguard Personalized Indexing Management LLC lifted its stake in Encompass Health by 0.6% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 15,871 shares of the company’s stock worth $2,016,000 after acquiring an additional 102 shares during the period. Finally, Leuthold Group LLC lifted its stake in Encompass Health by 0.3% in the fourth quarter. Leuthold Group LLC now owns 31,168 shares of the company’s stock worth $3,308,000 after acquiring an additional 104 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Encompass Health

In other news, Treasurer Edmund Fay sold 11,937 shares of the firm’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the completion of the transaction, the treasurer directly owned 89,325 shares in the company, valued at $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the transaction, the executive vice president owned 24,755 shares of the company’s stock, valued at $2,588,382.80. The trade was a 2.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.80% of the stock is owned by company insiders.

Encompass Health Price Performance

EHC opened at $105.07 on Wednesday. The stock has a fifty day simple moving average of $103.05 and a two-hundred day simple moving average of $105.58. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. The company has a market cap of $10.42 billion, a price-to-earnings ratio of 17.54, a price-to-earnings-growth ratio of 2.29 and a beta of 0.72. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.51 by $0.09. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Research analysts predict that Encompass Health Corporation will post 5.96 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.19 per share. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 12.69%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on EHC. Barclays dropped their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Leerink Partners set a $152.00 price target on Encompass Health in a research note on Friday. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $145.29.

About Encompass Health

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.